Skip to content

A Study to Compare Yashtimadhu (Licorice) oral Gel and Placebo oral Gel in the Treatment of Mouth Ulcers (Stomatitis)

A Randomized, Controlled Study of topical application of Yashtimadhu Gel with Placebo Gel in the management of Mukhapaka (Stomatitis) A Symptom of Annavaha Srotas Dushti - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110042
Enrollment
32
Registered
2026-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K120- Recurrent oral aphthae

Interventions

None listed

Sponsors

Dr Samiksha Sanjeev Naik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects in age group 18 to 60 of either sex. 2.Those having only classical symptoms of Mukhapaka. 3.Willing to give written informed consent and comply to the treatment protocol. 4.Subjects having ulcers in the oral cavity. 5.Subjects presenting with signs and symptoms of Stomatitis.

Exclusion criteria

Exclusion criteria: 1.Subjects below 18 years of age and above 60 years of age. 2.Associated symptoms i.e. fever, malaise and tender lymphadenopathy. 3.Ulcer formed due to malignancy, seropositive subjects. 4.Associated with complex autoimmune disorder including Bechet s syndrome, Reiter syndrome, IBS, SLE etc. 5.Cardiac complaints, diabetic and hypertensive subjects.

Design outcomes

Primary

MeasureTime frame
Overall clinical improvement in Mukhapaka (stomatitis), measured by reduction in pain and burning sensation (Daha), healing of oral ulcers (Vrana/Paka) and improvement in WHO Mucositis Scale score. Timepoint: Baseline and Day 7

Secondary

MeasureTime frame
1.Improvement in difficulty in eating/ mastication (Ahara Sevana Kashtata) 2.Reduction in improper taste (Asyavairasyata) 3.Reduction in hyper salivation 4.Reduction in inflammation (Shotha) 5.Change in salivary pH 6.Reduction in number of vesicles (Pidakas) Timepoint: Baseline and Day 7

Countries

India

Contacts

Public ContactDr Basil Cardozo

BSPs Gomantak Ayurveda Mahavidyalaya and Research Centre, Vazem, Shiroda, North Goa, India

cardozobasil@gmail.com9890501020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026